Simple Questionnaire Helps ED Clinicians Identify Patients for Recovery
The use of the CAGE-AID screening tool in the emergency department was linked to increased referral to an addiction recovery coach for treatment of substance use disorders.
Treatments
Top May & June 2022 FDA Approvals
May and June 2022 FDA approvals include treatments from alopecia areata, H. pylori, Crohn disease, plaque psoriasis, and Wilson disease.
More Clinical Benefits of Molnupiravir ID’d in COVID-19
Researchers examined other potential clinical benefits of molnupiravir versus placebo in a secondary analysis of data from a randomized phase 3 component of the MOVe-OUT trial.
CDC Issues Guidance on COVID-19 Rebound After Paxlovid Treatment
Recent case reports suggest that some patients treated with Paxlovid may have a recurrence of COVID-19 symptoms 2 to 8 days after completing the 5-day course.
Top April 2022 FDA Approvals
April 2022 FDA approvals include treatments for pediatric urinary tract infections, topical rosacea, vulvovaginal candidiasis, and various types of cancer.
COVID-19 Drug Paxlovid Might Also Fight Long COVID
Series of case reports shows some success with Paxlovid in treating patients with long COVID.
Efficacy of Different Acupuncture Therapies for Primary Insomnia
In a systematic review and meta-analysis, researchers compared and evaluated the effect differences of multiple acupuncture therapies for patients with primary insomnia.
Metformin and Improved Clinical Outcomes in Comorbid Heart Failure and Diabetes
Researchers sought to evaluate the relationship between initiation of metformin and sulfonylurea therapy and clinical outcomes in patients with HF and diabetes.
Brexpiprazole May Improve Functioning in Patients With Schizophrenia
Some patients with schizophrenia may experience residual symptoms when treated with antipsychotics, due in part to their side effects. This analysis aims to examine both short-term improvement and residual symptoms of prescribed medication.
Clinical, Demographic Factors for Early Identification of Children at Risk for Severe COVID-19
Researchers conducted a study to determine the clinical and demographic characteristics associated with an increased risk for severe COVID-19 infection among children.
- Loading...
Loading...
Next post in Pediatrics Information Center
Loading... 
Loading...